Recalls / Active ingredient / Irinotecan Hydrochloride
Irinotecan Hydrochloride
6 FDA drug recalls involving the active ingredient “Irinotecan Hydrochloride”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2020-06-11 | Class II | Irinotecan HCL Injection, USP, 100mg/5mL, 5 mL vials, Rx only, Manufactured by: Thymoorgan Pharmazie GmbH, Shi | Hikma Pharmaceuticals USA Inc. |
| 2020-06-11 | Class II | Irinotecan HCL Injection, USP, 100mg/5mL, 5 mL vials, Rx only, Manufactured by: Thymoorgan Pharmazie GmbH, Shi | Hikma Pharmaceuticals USA Inc. |
| 2018-06-08 | Class II | Irinotecan Hydrochloride Injection, USP, 40 mg/2 mL (20 mg/mL), 1 x 2 mL Single Dose Vial, Rx Only, Manufactur | Ingenus Pharmaceuticals Llc |
| 2018-06-08 | Class II | Irinotecan Hydrochloride Injection, USP, 100 mg/5 mL (20 mg/mL), 1 x 5 mL Single Dose Vial, Rx Only, Manufactu | Ingenus Pharmaceuticals Llc |
| 2013-09-23 | Class II | Irinotecan Hydrochloride Injection, 100 mg/5 mL (20 mg/mL), 1 x 5 mL Single Dose Vial per carton, Rx only, Man | West-Ward Pharmaceutical Corp. |
| 2013-09-23 | Class II | Irinotecan Hydrochloride Injection, 40 mg/2 mL (20 mg/mL), 1 x 2 mL Single Dose Vial per carton, Rx only, Manu | West-Ward Pharmaceutical Corp. |